MedPath

ROSWELL PARK CANCER INSTITUTE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

403

Active:17
Completed:196

Trial Phases

6 Phases

Early Phase 1:12
Phase 1:130
Phase 2:124
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (391 trials with phase data)• Click on a phase to view related trials

Phase 1
130 (33.2%)
Phase 2
124 (31.7%)
Not Applicable
118 (30.2%)
Early Phase 1
12 (3.1%)
Phase 3
5 (1.3%)
Phase 4
2 (0.5%)

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

Not Applicable
Recruiting
Conditions
Smokeless Tobacco
First Posted Date
2025-08-06
Last Posted Date
2025-08-06
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
50
Registration Number
NCT07107139
Locations
🇺🇸

Roswell Park, Buffalo, New York, United States

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Not Applicable
Recruiting
Conditions
Smoking Behaviors
First Posted Date
2025-08-03
Last Posted Date
2025-08-03
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
160
Registration Number
NCT07102082
Locations
🇺🇸

Roswell Park, Buffalo, New York, United States

Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma

Not Applicable
Not yet recruiting
Conditions
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
Interventions
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Computed Tomography
Procedure: Echocardiography Test
Procedure: Magnetic Resonance Imaging
Procedure: Multigated Acquisition Scan
Procedure: Positron Emission Tomography
Other: Questionnaire Administration
First Posted Date
2025-07-24
Last Posted Date
2025-08-12
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
21
Registration Number
NCT07082270
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy

Not Applicable
Not yet recruiting
Conditions
Prostate Carcinoma
First Posted Date
2025-07-20
Last Posted Date
2025-08-01
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
138
Registration Number
NCT07075705
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

A Food Security Intervention for the Prevention of Cancer in Low-income Families

Not Applicable
Not yet recruiting
Conditions
Obesity-Related Malignant Neoplasm
First Posted Date
2025-06-26
Last Posted Date
2025-07-18
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
50
Registration Number
NCT07039630
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 81
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.